Marta Hernández-Andreu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marta Hernández-Andreu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Anna Pons-Rodríguez
Example Basic Health Area, Catalan Institute of Health, 25006 Lleida, Spain
1 shared publication - Carles Forné
Heorfy Consulting, 25007 Lleida, Spain
1 shared publication - Celmira Laza Vásquez
Universidad Surcolombiana, Colombia
1 shared publication - Cristina Cazorla-Sánchez
Primer de Maig Basic Health Area, Catalan Institute of Health, 25003 Lleida, Spain
1 shared publication - Gisela Galindo Ortego
Sociedad Española de Medicina de Familia y Comunitaria)
1 shared publication - Inés Cruz
Primary Care Research Institute IDIAP Jordi Gol, Catalan Institute of Health, Lleida, Spain
1 shared publication
Latest Publications
- Open Access
- 21 August 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (16) , 10426
Feasibility and Acceptability of Personalized Breast Cancer Screening (DECIDO Study): A Single-Arm Proof-of-Concept Trial
The aim of this study was to assess the acceptability and feasibility of offering risk-based breast cancer screening and its integration into regular clinical practice. A single-arm proof-of-concept trial was conducted with a sample of 387 women aged 40–50 years residing in the city of Lleida (Spain). The study intervention consisted of breast cancer risk estimation, risk communication and screening recommendations, and a follow-up. A polygenic risk score with 83 single nucleotide polymorphisms was used to update the Breast Cancer Surveillance Consortium risk model and estimate the 5-year absolute risk of breast cancer. The women expressed a positive attitude towards varying the frequency of breast screening according to individual risk and, especially, more frequently inviting women at higher-than-average risk. A lower intensity screening for women at lower risk was not as welcome, although half of the participants would accept it. Knowledge of the benefits and harms of breast screening was low, especially with regard to false positives and overdiagnosis. The women expressed a high understanding of individual risk and screening recommendations. The participants’ intention to participate in risk-based screening and satisfaction at 1-year were very high.
- 21 August 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (16) , 10426
Open AccessFeasibility and Acceptability of Personalized Breast Cancer Screening (DECIDO Study): A Single-Arm Proof-of-Concept Trial
The aim of this study was to assess the acceptability and feasibility of offering risk-based breast cancer screening and its integration into regular clinical practice. A single-arm proof-of-concept trial was conducted with a sample of 387 women aged 40–50 years residing in the city of Lleida (Spain). The study intervention consisted of breast cancer risk estimation, risk communication and screening recommendations, and a follow-up. A polygenic risk score with 83 single nucleotide polymorphisms was used to update the Breast Cancer Surveillance Consortium risk model and estimate the 5-year absolute risk of breast cancer. The women expressed a positive attitude towards varying the frequency of breast screening according to individual risk and, especially, more frequently inviting women at higher-than-average risk. A lower intensity screening for women at lower risk was not as welcome, although half of the participants would accept it. Knowledge of the benefits and harms of breast screening was low, especially with regard to false positives and overdiagnosis. The women expressed a high understanding of individual risk and screening recommendations. The participants’ intention to participate in risk-based screening and satisfaction at 1-year were very high.